Is Aurora Cannabis (TSX:ACB) Stock a Buy Right Now?

Big changes keep happening at Aurora Cannabis (TSX:ACB)(NYSE:ACB) this year. The marijuana producer has significantly restructured its operations and balance sheet as industry focus turns from growth to profitability. The big question for investors is whether Aurora Cannabis stock is a buy or sell after the latest restructuring update announced on Tuesday. What’s happening at Aurora Cannabis? Aurora is suspending…

Read More

Canopy Growth (TSX:WEED) Stock: $0 or $100?

Industries across the board continue to suffer thanks to the COVID-19 pandemic. It seems no industry immune to the financial devastation it can cause, including the cannabis industry. Despite the increase in demand and sales of cannabis while people stay home, that hasn’t fixed the problem cannabis suppliers like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) continue to have: a means of supplying that…

Read More

Pot Stock Alert: This Company Just Spiked 146%

Pot stocks have been a roller coaster ride this year. At the start of 2020, cannabis companies were hit hard by the coronavirus correction. These pressures came after the terrible marijuana bear market of 2019, which saw industry valuations cut in half. Recent weeks, however, have brought much-needed relief. Indeed, some companies are seeing their share prices soar. One of…

Read More

The #1 Pot Stock to Buy During the Market Rally

The market rally picked up steam in recent weeks, yet many pot stocks remain depressed — and for good reason. If you want to go bargain shopping for marijuana stocks, you need to be careful. Today, some pot stocks are priced at ridiculous valuations. Fortunes are ready to be made. Other pot stocks, however, face a difficult future — one…

Read More

1 Cannabis Stock I’m Buying While It’s Still Cheap

You’ll think I’m crazy, but with markets at lows not seen in years, perhaps the craziness of the market place is getting to me. I’ve been looking hard for cheap stocks to buy up while I can. Whereas before I would have to have a couple thousand dollars stashed away, right now I might need only a couple hundred bucks…

Read More

Now Is the Time to Bet on Pot Stocks

Pot stocks were hammered in 2019. Nearly every company lost at least 50% of its value. Cannabis demand, on the other hand, continues to climb. This disconnect provides patient investors a clear path to profit. As with any early-stage market, investors scrambled at the chance to inject pent-up capital into cannabis companies. In 2018, many pot stocks rose by more…

Read More

If You’re Going to Buy Weed, Buy It in Aggregate

If you haven’t noticed, Canadian cannabis producers are risky to own. The same volatility that allowed these companies to double on a weekly basis has allowed some of the same names to halve a weekly basis. Here’s my take on why investors looking to invest in cannabis ought to buy the Exchange-Traded Fund (ETF) tracking the sector: the Horizons Marijuana…

Read More

This Is the Most Important Driver for Cannabis Investors!

For cannabis investors who continue to hold positions in any of Canada’s cannabis producers, every news cycle seems to bring unwanted negative news, driving volatility in the sector and valuations lower, as many take money off the table after a wild ride that has seen valuations reach astronomical levels. Determining what precisely has driven this volatility and scared many investors…

Read More

Aurora Cannabis (TSX:ACB) Revenue Falls 26%: Time to Sell the Stock?

This past week, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) released its earnings for the second quarter of 2020, and they were, predictably, bad. The company reported a 26% drop in net revenue along with a colossal $1.3 billion GAAP net loss. While the net loss was mostly due to a goodwill impairment charge, the company also reported a $80 million adjusted EBITDA loss that…

Read More

Top Pot Stocks for the Next Generation of Cannabis Products

It’s time for a new chapter in pot investing. In 2018, cannabis stocks soared as the market rushed to take advantage. Last year, the tides turned, as valuations came down from nosebleed levels. In 2020, the story will evolve again, even if few investors are prepared. The biggest shift will be a newfound appreciation for novel cannabis form factors. In…

Read More